Filing Details

Accession Number:
0001591986-25-000002
Form Type:
13G Filing
Publication Date:
2025-02-13 19:00:00
Filed By:
Aquilo Capital Management
Company:
Precision Biosciences Inc (NASDAQ:DTIL)
Filing Date:
2025-02-14
SEC Url:
13G Filing
Ownership Summary

Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.

Name Beneficially Owned Number of Shares Beneficially Owned Number of Aggregate Shares Percent of Class
Aquilo Capital, L.P. 0 521,372 6.6%
Aquilo Capital Management, LLC 0 791,862 9.9%
Marc Schneidman 0 791,862 9.9%
Filing





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Checkbox checked   Rule 13d-1(b)
Checkbox not checked   Rule 13d-1(c)
Checkbox not checked   Rule 13d-1(d)






SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G




SCHEDULE 13G


 
Aquilo Capital, L.P.
 
Signature:/s/ Marc Schneidman
Name/Title:Aquilo Capital Management, LLC, its General Partner
Date:02/14/2025
 
Aquilo Capital Management, LLC
 
Signature:/s/ Marc Schneidman
Name/Title:Managing Member
Date:02/14/2025
 
Marc Schneidman
 
Signature:/s/ Marc Schneidman
Name/Title:Marc Schneidman
Date:02/14/2025